https://www.scinai.com/careers daily 0.75 2026-01-01 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/107021ee-e063-404c-8eb2-fd67d94c8510/WhatsApp+Image+2022-03-16+at+1.05.51+PM.jpeg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/2d044ddd-c0c1-4e72-babb-f66350819b78/image-asset.jpg https://www.scinai.com/careers/blog-post-title-four-49b2a monthly 0.5 2025-12-03 https://www.scinai.com/in-the-news daily 0.75 2025-03-03 https://www.scinai.com/in-the-news/scinai-immunotherapeutics-featured-in-the-marker-labels-biomed-magazine monthly 0.5 2025-03-03 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/2df3d7b0-96f1-42b7-84df-e840c4323483/Articale.png In The News - Scinai Immunotherapeutics featured in The Marker Labels Biomed Magazine - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.scinai.com/in-the-news/biomed-wire-featuring-amir-recihman-ceo-of-scinai-immunotherapeutics-scni monthly 0.5 2024-09-22 https://www.scinai.com/in-the-news/smart-money-circle-podcast monthly 0.5 2024-09-22 https://www.scinai.com/in-the-news/biologics-development-in-immunology-and-inflammation-featuring-amir-reichman-ceo-of-scinai-immunotherapeutics monthly 0.5 2024-02-29 https://www.scinai.com/in-the-news/no-camels-biopharma-company-sees-success-in-trial-for-psoriasis-jab monthly 0.5 2023-12-26 https://www.scinai.com/in-the-news/fierce-pharma-biondvax-rebrand-scinai-6sep2023 monthly 0.5 2023-09-07 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/2d99919c-1d37-4e63-aff5-156cf7ce659b/Fierce-Pharma-logo In The News - BiondVax Pharmaceuticals hits branding reset to become Scinai Immunotherapeutics amid a troubled year - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.scinai.com/in-the-news/jnp21l5bvdpminq6hr334knoscg99l monthly 0.5 2024-01-16 https://www.scinai.com/in-the-news/bell2bell-podcast-featuring-amir-reichman-ceo monthly 0.5 2023-09-03 https://www.scinai.com/in-the-news/nasdaq-these-are-some-of-the-best-ideas-from-the-bio-europe-spring-conference monthly 0.5 2023-08-31 https://www.scinai.com/in-the-news/test-optimize-scale-podcast-episode-101-featuring-amir-reichman monthly 0.5 2023-09-03 https://www.scinai.com/press-releases daily 0.75 2026-04-02 https://www.scinai.com/press-releases/scinai-reports-full-year-2025-results-with-cdmo-revenues-doubling-and-strategic-expansion-through-recipharm-collaboration monthly 0.5 2026-04-02 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/758e2406-3cba-4b6c-8ac0-09819ae3a1d9/PR+website+01apr2026+corrected.png Press Release - Scinai Reports Full-Year 2025 Results, with CDMO Revenues Doubling and Strategic Expansion Through Recipharm Collaboration - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.scinai.com/press-releases/scinai-immunotherapeutics-highlights-expanded-cdmo-platform-and-immunology-pipeline-at-bio-europe-spring-2026 monthly 0.5 2026-03-19 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/d1fec026-a89f-49af-87d0-4c7c9fd4e3a6/PR+Website%403x.jpg Press Release - Scinai Immunotherapeutics Highlights Expanded CDMO Platform and Immunology Pipeline at BIO-Europe Spring® 2026 - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.scinai.com/press-releases/scinai-signs-second-amendment-to-pincell-option-agreement-and-submits-revised-12-million-non-dilutive-feng-application-to-advance-pc111-through-human-proof-of-concept monthly 0.5 2026-03-02 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/609727ec-495e-4c46-8aaa-f51ae53b5417/2nd+amendment+FENG.jpg Press Release - Scinai Signs Second Amendment to PinCell Option Agreement and Submits Revised €12 Million Non-Dilutive FENG Application to Advance PC111 Through Human Proof of Concept - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.scinai.com/press-releases/scinai-announces-expanded-israel-innovation-authority-support-for-robotic-aseptic-fill-amp-finish-platform monthly 0.5 2026-02-25 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/6c058aed-e9e7-4963-8dcf-531aabe4a4d2/PR_Pincellinnovation+authority+pr.jpg Press Release - Scinai Announces Expanded Israel Innovation Authority Support for Robotic Aseptic Fill &amp; Finish Platform - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.scinai.com/press-releases/scinai-announces-completion-of-acquisition-of-recipharm-israel-ltd-and-strategic-commercial-collaboration-with-recipharm monthly 0.5 2026-02-17 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e7a4b900-1517-4b44-a498-3816d254e391/Scinai_Recipharm_Israel_PR_Banner_300dpi.jpg Press Release - Scinai Announces Completion of Acquisition of Recipharm Israel Ltd. and Strategic Commercial Collaboration with Recipharm - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.scinai.com/press-releases/scinai-ceo-amir-reichman-to-co-lead-manufacturers-association-biopharma-manufacturing-roundtable-at-healthil monthly 0.5 2026-01-07 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/d2db4bbe-d9f9-4b07-be93-68e894b634a9/HEALTH+IL+EXPO+19_01_26+copy.jpg Press Release - Scinai CEO Amir Reichman to Co-Lead Manufacturers Association Biopharma Manufacturing Roundtable at HealthIL - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.scinai.com/press-releases/scinai-reports-nine-month-2025-results-as-cdmo-growth-continues-and-nanoabs-pipeline-advances monthly 0.5 2025-12-02 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/438736c7-f4d2-4c15-9e09-4934fdc27c19/Q3+2025+financial+results+02dec25.jpg Press Release - Scinai Reports Nine-Month 2025 Results as CDMO Growth Continues and NanoAbs Pipeline Advances - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.scinai.com/press-releases/ftt04u6rawfo7mbj9avs1vvg16t7sg monthly 0.5 2025-10-06 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/ed0333b2-9f62-4ca8-bba2-2c5e452c9c3c/PR_Pincellinnovation+authority+1_1.jpg Press Release - Scinai Awarded Israel Innovation Authority Grant to Expand Fill-and-Finish CDMO Capabilities - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.scinai.com/press-releases/scinai-reports-six-month-2025-financial-results-highlighting-continued-cdmo-revenue-growth-and-strengthened-balance-sheet monthly 0.5 2025-09-02 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/684337db-edb6-46ff-8255-111f055c8538/2025+1H+financial+results.png Press Release - Scinai Reports Six-Month 2025 Financial Results Highlighting Continued CDMO Revenue Growth and Strengthened Balance Sheet - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.scinai.com/press-releases/scinai-announces-new-peer-reviewed-publication-supporting-pc111-as-a-disease-modifying-therapy-for-pemphigus-and-sjsten monthly 0.5 2025-07-29 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/64731fec-3e52-4972-b1e5-443719ae9be3/Webpage+Design+%281400+x+700+px%29.png Press Release - Scinai Announces New Peer-Reviewed Publication Supporting PC111 as a Disease-Modifying Therapy for Pemphigus and SJS/TEN - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.scinai.com/press-releases/scinai-highlights-award-winning-science-behind-pc111-as-key-pincell-researcher-receives-oscar-of-italian-dermatology monthly 0.5 2025-06-26 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/a47f7bf8-d1f8-494c-95a0-4331049bb1fc/pincell+pr+linkedin_oscar+%281%29.jpg Press Release - Scinai Highlights Award-Winning Science Behind PC111 as Key Pincell Researcher Receives "Oscar of Italian Dermatology" - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.scinai.com/press-releases/scinai-highlights-new-funding-and-cdmo-growth-ahead-of-bio-international-convention-2025 monthly 0.5 2025-06-12 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/deee7136-3bab-439a-86d7-963eb8be3d5d/CDMO+Growth+Linkedin.jpg Press Release - Scinai Highlights New Funding and CDMO Growth Ahead of BIO International Convention 2025 - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.scinai.com/press-releases/scinai-immunotherapeutics-receives-italian-government-clearance-under-golden-power-regulation-for-potential-acquisition-of-pincell-srl monthly 0.5 2025-06-08 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/645e4e58-e2ff-4e81-a12c-9da337305120/pincell+pr.jpg Press Release - Scinai Immunotherapeutics Receives Italian Government Clearance Under Golden Power Regulation for Potential Acquisition of Pincell S.r.l. - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.scinai.com/press-releases/scinai-reports-q1-2025-financial-results-highlighting-strong-cdmo-revenue-momentum-and-reduced-cash-burn monthly 0.5 2025-05-30 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/084093b6-1c0b-483e-bb93-1edcc584a0a5/linkedin_Q1_2025.jpg.png Press Release - Scinai Reports Q1 2025 Financial Results Highlighting Strong CDMO Revenue Momentum and Reduced Cash Burn - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.scinai.com/press-releases/scinai-announces-annual-financial-results-for-2024 monthly 0.5 2025-07-06 https://www.scinai.com/press-releases/scinai-immunotherapeutics-and-pincell-to-host-webinar-on-a-blockbuster-drug-candidate-for-devastating-rare-skin-diseases monthly 0.5 2025-05-04 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/6e610942-3e3e-404d-bfa3-abcf2e2b1c3d/1744837985631.jfif Press Release - Scinai Immunotherapeutics and Pincell to Host Webinar on a Blockbuster Drug Candidate for Devastating Rare Skin Diseases - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.scinai.com/press-releases/scinai-signs-an-option-agreement-to-acquire-rare-disease-company-pincell-and-its-novel-antibody-for-treating-severe-dermatological-conditions monthly 0.5 2025-03-27 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/3f90fd8f-6100-4cdb-8032-bd47496c488d/pincell.jpg Press Release - Scinai signs an option agreement to acquire rare disease company Pincell and its novel antibody for treating Severe Dermatological Conditions - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.scinai.com/press-releases/bio-europe-spring monthly 0.5 2025-03-17 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/4131e9c3-1cc5-4690-943d-bf203df1374e/BIO-EUROPE+SPRING_PR+copy+%281%29.jpg Press Release - <span class="sqsrte-text-color--accent">Scinai to Connect with Investors, Showcase its Innovative I&amp;I pipeline and its Boutique cGMP Biologics CDMO during BIO-Europe Spring 2025</span> - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.scinai.com/press-releases/scinai-immunotherapeutics-announces-10-million-standby-equity-purchase-agreement monthly 0.5 2025-03-05 https://www.scinai.com/press-releases/jpm2025 monthly 0.5 2025-01-06 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/67c198f2-5f96-4cbb-b209-6b4c10e9b76d/linkedin-100+%285%29.jpg Press Release - Scinai to Connect with Investors and Pharma Leaders at Upcoming Key US Conferences - Make it stand out Meet Scinai Leaderhsip at Mini Mixii Mayami and JPM Healthcare conferences https://www.scinai.com/press-releases/scinai-immunotherapeutics-establishes-us-subsidiary-for-cdmo-business-unit-scinai-bioservices-inc monthly 0.5 2024-12-16 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/1734377849067-L54T454VFJMCG73IS7T7/U.S.+Subsidiary.jpg Press Release - Scinai Immunotherapeutics Establishes U.S. Subsidiary for CDMO Business Unit, Scinai Bioservices Inc. - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.scinai.com/press-releases/prof-michael-schn-director-of-dermatology-and-venereology-at-the-university-medical-center-gttingen-germany-umg-joins-scinai-immunotherapeutics-scientific-advisory-board monthly 0.5 2024-12-05 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/fa6daa35-8a5e-4e69-b396-1b619afe9341/Scinai_welcome_Michael.jpg Press Release - Prof. Michael Schön, Director of Dermatology and Venereology at the University Medical Center Göttingen, Germany (UMG), Joins Scinai Immunotherapeutics' Scientific Advisory Board - Make it stand out Prof. Michael Schön, Director of Dermatology and Venereology at the University Medical Center Göttingen, Germany (UMG), joins Scinai Immunotherapeutics' Scientific Advisory Board https://www.scinai.com/press-releases/dr-jonathan-sadeh-former-senior-vice-president-of-immunology-rampd-at-bristol-myers-squibb-joins-scinai-immunotherapeutics-scientific-advisory-board monthly 0.5 2024-11-27 https://www.scinai.com/press-releases/scinai-publishes-financial-results-and-provides-business-update-shareholders-equity-up-from-negative-73-million-as-of-june-30-2024-to-positive-10-million monthly 0.5 2024-11-22 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/c92ab807-fa08-466f-9e9c-26052078987f/linkedin+%285%29.jpg Press Release - Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up from negative $7.3 million as of June 30, 2024, to positive $10 million - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/1b472890-09c7-468f-b9bf-2e9d2e058e6a/table+1.png Press Release - Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up from negative $7.3 million as of June 30, 2024, to positive $10 million - Make it stand out SCINAI IMMUNOTHERAPEUTICS LTD. (Formerly known as BiondVax Pharmaceuticals Ltd.) – (Unaudited) . BALANCE SHEETS https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/9d39d6e1-acaa-43c2-a7c4-2a162e68f6c7/table+2.png Press Release - Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up from negative $7.3 million as of June 30, 2024, to positive $10 million - Make it stand out SCINAI IMMUNOTHERAPEUTICS LTD. (Formerly known as BiondVax Pharmaceuticals Ltd.) – (Unaudited) . BALANCE SHEETS https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b6b3142d-8eba-40e9-976c-7c5a5114738c/table+3.png Press Release - Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up from negative $7.3 million as of June 30, 2024, to positive $10 million - Make it stand out SCINAI IMMUNOTHERAPEUTICS LTD. (Formerly known as BiondVax Pharmaceuticals Ltd.) – (Unaudited) . STATEMENTS OF OPERATIONS https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/bd7c2b74-6395-435c-ae6d-880040a90fb6/table+4.png Press Release - Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up from negative $7.3 million as of June 30, 2024, to positive $10 million - Make it stand out SCINAI IMMUNOTHERAPEUTICS LTD. (Formerly known as BiondVax Pharmaceuticals Ltd.) – (Unaudited) . STATEMENTS OF COMPREHENSIVE LOSS https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/6d2a2e04-81bb-43d1-ae36-0b33a9a31304/table+5.png Press Release - Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up from negative $7.3 million as of June 30, 2024, to positive $10 million - Make it stand out SCINAI IMMUNOTHERAPEUTICS LTD. (Formerly known as BiondVax Pharmaceuticals Ltd.) – (Unaudited). STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/71282564-49d9-4462-8bc0-43422c7ebe0a/table+6.png Press Release - Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up from negative $7.3 million as of June 30, 2024, to positive $10 million - Make it stand out SCINAI IMMUNOTHERAPEUTICS LTD. (Formerly known as BiondVax Pharmaceuticals Ltd.) – (Unaudited). STATEMENTS OF CASH FLOWS https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/70e50965-5bd5-43d5-a9c2-a87a9ea4f064/table+7.png Press Release - Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up from negative $7.3 million as of June 30, 2024, to positive $10 million - Make it stand out SCINAI IMMUNOTHERAPEUTICS LTD. (Formerly known as BiondVax Pharmaceuticals Ltd.) – (Unaudited). STATEMENTS OF CASH FLOWS https://www.scinai.com/press-releases/scinai-leadership-to-showcase-companys-cgmp-biologics-cdmo-and-innovative-iampi-pipeline-during-bio-europe-2024 monthly 0.5 2024-10-31 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/855000ef-22fb-4f26-9071-080c4ee29f80/Scinai_BIO-Europe_banner+copy.jpg Press Release - Scinai Leadership to Showcase Company’s cGMP Biologics CDMO and Innovative I&amp;I pipeline during BIO-Europe 2024 - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.scinai.com/press-releases/scinai-to-host-online-expert-panel-on-plaque-psoriasis-treatment-and-intralesional-injections-of-anti-il-17af-vhh-antibodies monthly 0.5 2024-09-16 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/4a1adb24-f5df-4bdf-a955-94d0769f6194/X-100.jpg Press Release - Scinai to Host Online Expert Panel on Plaque Psoriasis Treatment and Intralesional Injections of anti-IL-17A/F VHH Antibodies - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.scinai.com/press-releases/scinai-regains-full-compliance-with-nasdaq-listing-requirements monthly 0.5 2025-05-11 https://www.scinai.com/press-releases/scinai-announces-closing-of-loan-restructuring-agreement-with-european-investment-bank-converting-approximately-29-million-of-debt-to-preferred-equity-and-leaving-debt-balance-of-273000-nbsp monthly 0.5 2024-08-21 https://www.scinai.com/press-releases/scinai-announces-entering-into-2-million-private-equity-commitment-agreement-with-its-largest-existing-shareholder monthly 0.5 2024-08-20 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/d2743046-4f2f-49e6-bf19-87a11618e7a9/Scinai_Amir_Q2%2BFinancial%2BResults_linkedin%2Bevent.jpg Press Release - Scinai Announces Entering into $2 Million Private Equity Commitment Agreement with its largest Existing Shareholder - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.scinai.com/press-releases/scinai-publishes-q2-2024-financial-results-and-provides-business-update-restructures-29-million-bank-loan-to-equity-andnbspregains-nasdaq-compliance monthly 0.5 2024-08-15 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/c68c408b-eeb0-4e40-8674-e39a1dc6f187/Scinai_Amir_Q2+Financial+Results_linkedin+event.jpg Press Release - Scinai Publishes Q2 2024 Financial Results and Provides Business Update; Restructures $29 Million Bank Loan to Equity; On Track to Regain Nasdaq Compliance by August 23 - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/639d7bd3-693f-4bbc-b989-c09d5aad4309/01.jpg Press Release - Scinai Publishes Q2 2024 Financial Results and Provides Business Update; Restructures $29 Million Bank Loan to Equity; On Track to Regain Nasdaq Compliance by August 23 - BALANCE SHEETS https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/9334cb57-40c0-4c3b-90d8-16fc7775442f/02+copy.jpg Press Release - Scinai Publishes Q2 2024 Financial Results and Provides Business Update; Restructures $29 Million Bank Loan to Equity; On Track to Regain Nasdaq Compliance by August 23 - BALANCE SHEETS https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/33d7903e-b22d-4558-90e1-8dfe4d6f530a/03+copy.jpg Press Release - Scinai Publishes Q2 2024 Financial Results and Provides Business Update; Restructures $29 Million Bank Loan to Equity; On Track to Regain Nasdaq Compliance by August 23 - STATEMENTS OF OPERATIONS https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/f13f0dd9-8540-4291-b2ac-adacffeb5583/03+copy.jpg Press Release - Scinai Publishes Q2 2024 Financial Results and Provides Business Update; Restructures $29 Million Bank Loan to Equity; On Track to Regain Nasdaq Compliance by August 23 - STATEMENTS OF OPERATIONS https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/2160945d-6fcb-4c39-a135-f8fcfafe2ef0/04+copy.jpg Press Release - Scinai Publishes Q2 2024 Financial Results and Provides Business Update; Restructures $29 Million Bank Loan to Equity; On Track to Regain Nasdaq Compliance by August 23 - STATEMENTS OF COMPREHENSIVE LOSS https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/28fcf004-c2cc-4c9f-abc8-893c0ee9f5bb/05-1+copy.jpg Press Release - Scinai Publishes Q2 2024 Financial Results and Provides Business Update; Restructures $29 Million Bank Loan to Equity; On Track to Regain Nasdaq Compliance by August 23 - STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/433b03a2-828d-47c2-97d6-5110d007ceae/06+copy.jpg Press Release - Scinai Publishes Q2 2024 Financial Results and Provides Business Update; Restructures $29 Million Bank Loan to Equity; On Track to Regain Nasdaq Compliance by August 23 - STATEMENTS OF CASH FLOWS https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/90f764ab-8d4d-4e24-a471-d2a159bf24e4/07+copy.jpg Press Release - Scinai Publishes Q2 2024 Financial Results and Provides Business Update; Restructures $29 Million Bank Loan to Equity; On Track to Regain Nasdaq Compliance by August 23 - STATEMENTS OF CASH FLOWS https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/f87a7d9a-0eb7-411b-ac86-21311686ffcf/Scinai_new_CDMO_Section-07.jpg Press Release - Scinai Publishes Q2 2024 Financial Results and Provides Business Update; Restructures $29 Million Bank Loan to Equity; On Track to Regain Nasdaq Compliance by August 23 Company Contacts Investor Relations | +972 8 930 2529 | ir@scinai.com Business Development | +972 8 930 2529 | bd@scinai.com https://www.scinai.com/press-releases/nbspscinai-announces-signing-of-loan-restructuring-agreement-witheuropean-investment-bank-converting-approximately-29-million-of-debt-to-preferred-equity-convertible-into-195-common-equity monthly 0.5 2024-08-13 https://www.scinai.com/press-releases/scinai-immunotherapeutics-announces-positive-regulatory-feedback-from-the-pei-on-the-path-for-phase-12a-in-plaque-psoriasis-with-its-anti-il-17-nanoab-1 monthly 0.5 2025-05-11 https://www.scinai.com/press-releases/scinai-immunotherapeutics-announces-promising-results-in-an-in-vivo-proof-of-concept-psoriatic-human-skin-model monthly 0.5 2025-05-11 https://www.scinai.com/press-releases/scinai-immunotherapeutics-announces-receipt-of-an-updated-letter-of-intent-from-the-european-investment-bank-providing-specific-terms-for-conversion-of-its-loan-to-equity monthly 0.5 2025-05-11 https://www.scinai.com/press-releases/scinai-immunotherapeutics-granted-extension-by-nasdaq-hearing-panel-to-regain-compliance-with-continued-listing-requirements monthly 0.5 2025-05-11 https://www.scinai.com/press-releases/scinai-publishes-q1-2024-financial-results-and-provides-business-update monthly 0.5 2024-07-31 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/9f1af2b0-c8d8-4129-a682-eccc42313bcd/01+copy.png Press Release - Scinai Publishes Q1 2024 Financial Results and Provides Business Update - SCINAI IMMUNOTHERAPEUTICS LTD. (Formerly known as BiondVax Pharmaceuticals Ltd.) BALANCE SHEETS U.S. dollars in thousands (except share and per share data) https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/543de8eb-18a7-452b-9daf-389ba16a2cfe/02+copy.png Press Release - Scinai Publishes Q1 2024 Financial Results and Provides Business Update - SCINAI IMMUNOTHERAPEUTICS LTD. (Formerly known as BiondVax Pharmaceuticals Ltd.) BALANCE SHEETS U.S. dollars in thousands (except share and per share data) https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/2d09c87f-c256-441f-a86a-094698f251fe/03+copy.png Press Release - Scinai Publishes Q1 2024 Financial Results and Provides Business Update - SCINAI IMMUNOTHERAPEUTICS LTD. (Formerly known as BiondVax Pharmaceuticals Ltd.) STATEMENTS OF OPERATIONS U.S. dollars in thousands (except share and per share data) https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/74d3b87e-bb31-4c08-9208-93e0a150179c/04+copy.png Press Release - Scinai Publishes Q1 2024 Financial Results and Provides Business Update - SCINAI IMMUNOTHERAPEUTICS LTD. (Formerly known as BiondVax Pharmaceuticals Ltd.) STATEMENTS OF COMPREHENSIVE LOSS U.S. dollars in thousands (except share and per share data) https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/fa12f5dc-d7c4-4ba4-b100-a148d9391276/05+copy.png Press Release - Scinai Publishes Q1 2024 Financial Results and Provides Business Update - SCINAI IMMUNOTHERAPEUTICS LTD. (Formerly known as BiondVax Pharmaceuticals Ltd.) STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY U.S. dollars in thousands (except share and per share data) https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e12b8dd7-daf0-4a6a-ba43-dbd1272ce0a1/06+copy.png Press Release - Scinai Publishes Q1 2024 Financial Results and Provides Business Update - SCINAI IMMUNOTHERAPEUTICS LTD. (Formerly known as BiondVax Pharmaceuticals Ltd.) STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY U.S. dollars in thousands (except share and per share data) https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/89647d23-f2c8-423a-add3-db29a69276ef/07+copy.png Press Release - Scinai Publishes Q1 2024 Financial Results and Provides Business Update - SCINAI IMMUNOTHERAPEUTICS LTD. (Formerly known as BiondVax Pharmaceuticals Ltd.) STATEMENTS OF CASH FLOWS U.S. dollars in thousands https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/58916d06-1bc5-40f2-9a69-d79ea6981477/08+copy.png Press Release - Scinai Publishes Q1 2024 Financial Results and Provides Business Update - SCINAI IMMUNOTHERAPEUTICS LTD. (Formerly known as BiondVax Pharmaceuticals Ltd.) STATEMENTS OF CASH FLOWS U.S. dollars in thousands (except share and per share data) https://www.scinai.com/press-releases/scinai-immunotherapeutics-announces-receipt-of-a-letter-of-intent-from-the-european-investment-bank-providing-specific-terms-for-conversion-of-its-loan-to-equity monthly 0.5 2025-05-11 https://www.scinai.com/press-releases/scinai-immunotherapeutics-regains-compliance-with-nasdaq-minimum-bid-price-requirement-continues-to-work-with-the-european-investment-bank-to-convert-loan-to-equity monthly 0.5 2024-06-09 https://www.scinai.com/press-releases/scinai-immunotherapeuticsnbspannounces-receipt-of-a-nasdaq-staff-determination-letter-regarding-shareholders-equity-listing-requirements-and-hearing-to-present-a-plan-for-regaining-compliance-1 monthly 0.5 2025-05-11 https://www.scinai.com/press-releases/5la0ftqhjqbf3ovrlt4w732w5ebhs5 monthly 0.5 2025-05-11 https://www.scinai.com/press-releases/scinai-immunotherapeuticsnbspannounces-receipt-of-nasdaq-delisting-notification-and-appeal monthly 0.5 2025-05-11 https://www.scinai.com/press-releases/scinai-cso-dr-tamar-ben-yedidia-to-present-at-dermatology-drug-development-summit-together-with-prof-michael-schn-of-umg monthly 0.5 2025-05-11 https://www.scinai.com/press-releases/scinai-immunotherapeutics-cdmo-unit-selected-by-ayana-pharma-to-provide-drug-development-and-cgmp-manufacturing-services monthly 0.5 2025-05-11 https://www.scinai.com/press-releases/scinai-leadership-to-attend-bio-europe-spring-2024 monthly 0.5 2024-03-12 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/f21b7c4a-3e7d-4076-8e97-d1df161d454d/Scinai+at+BIOEuropeSpring+2024+-+for+website+and+social.gif Press Release - Scinai leadership to attend BIO-Europe Spring 2024 - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.scinai.com/press-releases/scinai-to-showcase-its-cgmp-biologics-cdmo-and-innovative-nanoab-pipeline-at-mixiii-2024 monthly 0.5 2024-02-29 https://www.scinai.com/press-releases/scinai-welcomes-liat-halpert-as-head-of-business-development-and-sales monthly 0.5 2024-02-13 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/1707819696677-BSRV50T3Z8N3LOL32W35/IMG_2881.jpg Press Release - Scinai Welcomes Liat Halpert as Head of Business Development and Sales - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.scinai.com/press-releases/scinai-immunotherapeutics-congratulates-its-co-lead-scientific-research-collaborator-dirk-grlich-on-louis-jeantet-prize monthly 0.5 2024-01-25 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/1706196140595-7XZ96DDOQ50JS611U0B8/Congratulations+to+Prof.+Dirk+Gorlich.png Press Release - Scinai Immunotherapeutics Congratulates its Co-Lead Scientific Research Collaborator Dirk Görlich on Louis-Jeantet Prize - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.scinai.com/press-releases/scinai-immunotherapeutics-announces-closing-of-exercise-of-outstanding-warrants-for-169-million-in-gross-proceeds monthly 0.5 2024-01-04 https://www.scinai.com/press-releases/scinai-immunotherapeutics-ceo-issues-letter-to-shareholders monthly 0.5 2024-01-04 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/7f7be75d-9b76-4a1f-b56b-304ca453abc7/New+Year+2024+CEO+Letter.jpg Press Release - Scinai Immunotherapeutics CEO Issues Letter to Shareholders - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e1127d70-e5b1-4187-963c-1e65b382996c/HypoSkin+model.png Press Release - Scinai Immunotherapeutics CEO Issues Letter to Shareholders - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.scinai.com/press-releases/scinai-immunotherapeutics-announces-exercise-of-outstanding-warrants-for-169-million-in-gross-proceeds monthly 0.5 2024-01-04 https://www.scinai.com/press-releases/scinai-nasdaq-scni-to-host-analyst-and-investor-webinar-on-january-9 monthly 0.5 2023-12-27 https://www.scinai.com/press-releases/scinai-announces-promising-results-in-a-psoriatic-human-skin-model monthly 0.5 2023-12-12 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e1127d70-e5b1-4187-963c-1e65b382996c/HypoSkin+model.png Press Release - Scinai Announces Promising Results in a Psoriatic Human Skin Model - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.scinai.com/press-releases/study-published-in-antiviral-research-supports-promise-of-scinai-immunotherapeutics-coronavirus-nanoab-as-aerosolized-prophylactic-and-therapeutic-drug monthly 0.5 2023-12-11 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/a7bbac6a-1113-4f9a-91a5-fae056f73a1c/Antiviral+Research+journal+cover+image+Sept+2023.jpg Press Release - Study published in Antiviral Research supports promise of Scinai Immunotherapeutics’ coronavirus NanoAb as aerosolized prophylactic and therapeutic drug - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.scinai.com/press-releases/european-investment-bank-eib-extends-maturity-of-its-finance-facility-with-scinai-immunotherapeutics-from-2027-to-2031 monthly 0.5 2023-11-29 https://www.scinai.com/press-releases/scinai-immunotherapeutics-regains-compliance-with-nasdaqs-stockholders-equity-rule monthly 0.5 2023-11-20 https://www.scinai.com/press-releases/scinai-immunotherapeutics-announces-award-of-non-dilutive-grant-from-israel-innovation-authority-supporting-its-new-cdmo-business-unit monthly 0.5 2023-11-20 https://www.scinai.com/press-releases/scinai-immunotherapeutics-provides-update-regarding-nasdaq-compliance monthly 0.5 2023-11-03 https://www.scinai.com/press-releases/european-investment-bank-eib-considering-extending-maturity-of-its-financial-facility-contract-with-scinai-immunotherapeutics-in-light-of-scinais-recent-strategic-pivot monthly 0.5 2023-10-31 https://www.scinai.com/press-releases/scinai-reports-third-quarter-2023-financial-results-and-provides-business-update monthly 0.5 2023-10-31 https://www.scinai.com/press-releases/scinai-immunotherapeutics-to-attend-bio-europe-munich-2023 monthly 0.5 2023-10-30 https://www.scinai.com/press-releases/scinai-immunotherapeutics-to-showcase-its-end-to-end-cgmp-biologics-cdmo-services-at-cphi-barcelona-2023 monthly 0.5 2023-10-04 https://www.scinai.com/press-releases/scinai-immunotherapeutics-announces-closing-of-133-million-registered-direct-offering monthly 0.5 2023-09-19 https://www.scinai.com/press-releases/scinai-immunotherapeutics-announces-133-million-registered-direct-offering monthly 0.5 2023-09-15 https://www.scinai.com/press-releases/scinai-immunotherapeutics-innovative-plaque-psoriasis-treatment-shows-encouraging-preclinical-results monthly 0.5 2023-09-14 https://www.scinai.com/press-releases/scinai-immunotherapeutics-ltd-to-participate-this-week-in-hc-wainwright-25th-annual-global-investment-conference-in-new-york-and-lsx-usa-congress-2023-in-boston monthly 0.5 2023-09-11 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/1694082778747-NYPGN56SL6I1U0BWJAY4/LSX+World+Congress+USA+2x1.jpg Press Release - Scinai Immunotherapeutics Ltd. to participate this week in H.C. Wainwright 25th Annual Global Investment Conference in New York and LSX USA Congress 2023 in Boston https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/1694082925187-D4X5SDL53OSP5IAAI472/HC-Wainwright-logo-2x1.jpg Press Release - Scinai Immunotherapeutics Ltd. to participate this week in H.C. Wainwright 25th Annual Global Investment Conference in New York and LSX USA Congress 2023 in Boston https://www.scinai.com/press-releases/biondvax-pharmaceuticals-ltd-rebrands-as-scinai-immunotherapeutics-ltd-to-reflect-new-focus-on-development-of-novel-inflammation-and-immunology-iampi-biological-therapeutics monthly 0.5 2023-10-04 https://www.scinai.com/press-releases/11august2023 monthly 0.5 2023-09-03 https://www.scinai.com/press-releases/1august2023 monthly 0.5 2023-09-03 https://www.scinai.com/press-releases/5june2023 monthly 0.5 2023-09-03 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/0f6aa048-9469-425e-8860-2775d6718f5f/post3.PNG Press Release - BiondVax signs exclusive license agreement for development and commercialization of a novel anti-IL-17 antibody for treatment of autoimmune and inflammatory diseases including psoriasis - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.scinai.com/press-releases/15may2023 monthly 0.5 2023-09-03 https://www.scinai.com/press-releases/17april2023 monthly 0.5 2023-09-03 https://www.scinai.com/press-releases/16mar2023 monthly 0.5 2023-09-03 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/eebc892d-3e83-409e-8926-7d5fd5ac5ef1/Capture.PNG Press Release - BiondVax to Present at BIO-Europe Spring - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.scinai.com/press-releases/2february2023 monthly 0.5 2023-09-03 https://www.scinai.com/press-releases/23january2023 monthly 0.5 2023-09-03 https://www.scinai.com/press-releases/6january2023 monthly 0.5 2023-09-03 https://www.scinai.com/press-releases/5january2023 monthly 0.5 2023-09-03 https://www.scinai.com/knowledge-center daily 0.75 2026-01-01 https://www.scinai.com/knowledge-center/precision-biologics-development monthly 0.5 2026-01-01 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/88624224-c2f6-4b02-9e36-40d86855cf43/Artboard+12-100.jpg KNOWLEDGE CENTER - the octet bio-layer interferometry technology Precision Biologics Development - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/10b76a7f-0573-4785-8081-064718815102/Artboard+12+copy+2-100.jpg KNOWLEDGE CENTER - the octet bio-layer interferometry technology Precision Biologics Development - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/47541240-b646-45c4-b72c-b4b3f04a1354/Artboard+12+copy+4-100.jpg KNOWLEDGE CENTER - the octet bio-layer interferometry technology Precision Biologics Development - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/6b554ce0-14c2-4795-b709-ca8aecd02f24/Artboard+12+copy+3-100.jpg KNOWLEDGE CENTER - the octet bio-layer interferometry technology Precision Biologics Development - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/1764538745200-PZ6XV9XHJEQZTCEL8WM9/Artboard+12+copy+3-100.jpg KNOWLEDGE CENTER - the octet bio-layer interferometry technology Precision Biologics Development https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/1764538781184-8DXYYFC1C4IFUZNP89BT/PXL_20230430_140357757.MP.jpg KNOWLEDGE CENTER - the octet bio-layer interferometry technology Precision Biologics Development https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/1764538748270-JX7MKQ3R5VYUE1O0X2AJ/Artboard+12+copy+4-100.jpg KNOWLEDGE CENTER - the octet bio-layer interferometry technology Precision Biologics Development https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/ea1795fb-71d3-469c-a6e4-b284729aa924/meirav.png KNOWLEDGE CENTER - the octet bio-layer interferometry technology Precision Biologics Development “At Scinai, the Octet platform isn’t just technology — it’s the engine driving smarter discovery, faster development, and uncompromising quality.” Merav Kamensky, Head of Quality Control and CMC Analytics, Scinai BioServices https://www.scinai.com/knowledge-center/capillary-electrophoresis monthly 0.5 2025-12-07 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/1764535445628-VRG58ZS2RBN9ZXKZ1PEJ/Artboard+12-100.jpg KNOWLEDGE CENTER - Precision Biopharmaceutical QC with Capillary Electrophoresis at Scinai BioServices - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/d4473114-20e9-49a7-8f78-0989da058170/Artboard+12+copy-100.jpg KNOWLEDGE CENTER - Precision Biopharmaceutical QC with Capillary Electrophoresis at Scinai BioServices - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/60ad1ace-a3ff-49b3-a5e9-bf5af3395e57/Artboard+12+copy+2-100.jpg KNOWLEDGE CENTER - Precision Biopharmaceutical QC with Capillary Electrophoresis at Scinai BioServices - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/add07b84-2a2b-4eea-9a42-feb3a61c4d2a/Artboard+12+copy+4-100.jpg KNOWLEDGE CENTER - Precision Biopharmaceutical QC with Capillary Electrophoresis at Scinai BioServices - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/1764536323491-RHRDF34QVMWBM3ICNE3C/Artboard+12+copy+2-100.jpg KNOWLEDGE CENTER - Precision Biopharmaceutical QC with Capillary Electrophoresis at Scinai BioServices https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/1764536323485-Y4B3MEYP8PITTWZQRVK5/Artboard+12+copy+3-100.jpg KNOWLEDGE CENTER - Precision Biopharmaceutical QC with Capillary Electrophoresis at Scinai BioServices https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/1764536326507-IRMV9R7MEE3VOQ1WU8V2/Artboard+12+copy+4-100.jpg KNOWLEDGE CENTER - Precision Biopharmaceutical QC with Capillary Electrophoresis at Scinai BioServices https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/1764536327277-8M2G21JUDT3CPQ07GKLA/Artboard+12+copy-100.jpg KNOWLEDGE CENTER - Precision Biopharmaceutical QC with Capillary Electrophoresis at Scinai BioServices https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/83d50d23-40bb-41ec-aed2-220d394f8997/SCINAI_CE+slide+deck.png KNOWLEDGE CENTER - Precision Biopharmaceutical QC with Capillary Electrophoresis at Scinai BioServices “At Scinai, Capillary Electrophoresis isn’t just a technique—it’s our commitment to precision. As a gold-standard method in biopharmaceutical development, CE drives the quality and accuracy of our work, ensuring every biologic we help develop is safe, effective, and consistent.” Limor Landsman, QC Expert, Scinai BioServices https://www.scinai.com/knowledge-center/akta-pure monthly 0.5 2025-12-07 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/80703d94-aa2b-473d-ae8e-27a84dbb42d9/Scinai_AKTA+carousel+deck.jpg KNOWLEDGE CENTER - Driving Bioprocess Innovation with ÄKTA Pure Technology - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/a10cdd07-2e2f-4b33-9038-521d8c6ef871/02.jpg KNOWLEDGE CENTER - Driving Bioprocess Innovation with ÄKTA Pure Technology - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/4a6c529d-6655-42d9-ac3a-6536f1431b4a/03.png KNOWLEDGE CENTER - Driving Bioprocess Innovation with ÄKTA Pure Technology - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/0238f3da-d917-4426-b020-246d9c3d5562/04.png KNOWLEDGE CENTER - Driving Bioprocess Innovation with ÄKTA Pure Technology - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/1764149461337-CMP83D7LMOS7BO9UYY3E/Artboard+2+copy+4-100.jpg KNOWLEDGE CENTER - Driving Bioprocess Innovation with ÄKTA Pure Technology https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/1764149461779-8ESZGXCZAOA7REPKAQEB/Artboard+2+copy+7-100.jpg KNOWLEDGE CENTER - Driving Bioprocess Innovation with ÄKTA Pure Technology https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/1764149465760-NACW7HAVLNTVYYHXAIF7/Artboard+2+copy+8-100.jpg KNOWLEDGE CENTER - Driving Bioprocess Innovation with ÄKTA Pure Technology https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/1764149466146-174ZAK8KMEJHHA4XU0JF/Artboard+2+copy+9-100.jpg KNOWLEDGE CENTER - Driving Bioprocess Innovation with ÄKTA Pure Technology https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/99ce7f80-bbe1-4be1-93f9-b9c016654b1c/bary.png KNOWLEDGE CENTER - Driving Bioprocess Innovation with ÄKTA Pure Technology “ÄKTA pure gives us the flexibility to efficiently test multiple parameters with DoE, enabling the design of robust processes at lab scale that are both reliable and data driven. These methods can then be seamlessly transferred into larger ÄKTA systems for GMP manufacturing. This integrated approach allows us to accelerate process development, ensure dependable scalability, and consistently deliver meaningful value to our partners.” Barry Cohen, Downstream R&D Team Manager, Scinai BioServices https://www.scinai.com/knowledge-center/ambr-250 monthly 0.5 2025-12-10 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/6e9a5292-a3e1-490d-a964-203dcc2fedc1/SCINAI_Amber_carousel.jpg KNOWLEDGE CENTER - Smarter Bioprocess Development with the AMBR 250 Fermenter System - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/699ce737-f55c-4df5-bad8-69f17abd67c8/Artboard+12+copy+6-100.jpg KNOWLEDGE CENTER - Smarter Bioprocess Development with the AMBR 250 Fermenter System - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/ec4260b4-2c9e-43fc-b2a7-12ad24b926f9/SCINAI_Amber_02.png KNOWLEDGE CENTER - Smarter Bioprocess Development with the AMBR 250 Fermenter System - How the AMBR 250 Works https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/56563221-73a4-44c5-9f7a-0650cbb46ed6/Artboard+12+copy+7-100.jpg KNOWLEDGE CENTER - Smarter Bioprocess Development with the AMBR 250 Fermenter System - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/1764533691707-I9A53V3W8KZ4BIWFHTG0/Artboard+12+copy+6-100.jpg KNOWLEDGE CENTER - Smarter Bioprocess Development with the AMBR 250 Fermenter System https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/1764533692056-0NF0KA45TNDCDTS99H8Y/Artboard+12+copy+7-100.jpg KNOWLEDGE CENTER - Smarter Bioprocess Development with the AMBR 250 Fermenter System https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/1764533695174-VSQV3LJVZ1LODWYQODI5/Artboard+12+copy+8-100.jpg KNOWLEDGE CENTER - Smarter Bioprocess Development with the AMBR 250 Fermenter System https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/add7b05a-c3b6-4519-94bb-28f640ae7876/SCINAI_Amber_carousel.png KNOWLEDGE CENTER - Smarter Bioprocess Development with the AMBR 250 Fermenter System “The AMBR fermentor system allows us to generate high-quality data faster and with far greater consistency — it’s a real game-changer for our CDMO workflows. Its automation, throughput, and reliable scale-down capabilities give us the confidence to optimize quickly and scale predictably.” Zohar Gadri, R&D Technology Expert & GMP Development Team Leader, Scinai BioServices https://www.scinai.com/scinai-immunotherapeutics daily 0.75 2025-11-16 https://www.scinai.com/team daily 0.75 2025-12-21 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/9b139db8-4575-4640-8948-6109bd1bdb7b/Amir+Reichman.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/f45e20e4-22c8-431c-b70e-456389821ee5/Elad+Mark.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/7a21bca3-2489-4662-a1e9-2e3793a52fc5/Uri_Ben_Or.webp https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/ee7f93fe-be89-45a1-843c-2245bf5236d5/IS2_0620.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/d529cdde-3c19-4fe8-b925-0070416ec112/DSC07555.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/8a6eff77-f01d-4d5c-ac7e-5809431359a1/DSC07638.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/ae045325-1663-43a7-ad3e-7a5875fa63a9/DSC07419.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/ccb0ad29-6c0b-4172-bed0-6d54d945e62b/DSC07497.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/8221483f-4c0d-4e83-a403-a440510cea8a/DSC07701+2.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/ddfbfd59-c226-4bfe-b537-3f9259e38140/Mark+Germain%2C+BiondVax+Chairman+of+the+Board+of+Directors.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/a9ac8613-339f-4b90-ab90-ec91f8d792c6/Samuel+Moed%2C+Director%2C+BiondVax+Pharmaceuticals+%28jpg%29.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/41a75c69-c44c-44f5-9841-ff89da6d1ffa/Jay+Green%2C+member+of+BiondVax%27s+Board+of+Directors_150x213.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/06d57f9d-dcb7-458a-b629-48ec817bc8fd/Adi+Raviv+-+BiondVax_opt.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/29cb627d-fb90-462d-a44c-f0f539598a05/amir.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/6dcc207c-ef55-4ffb-ac2f-c4843ba33ad8/Yael+Marolin.jpg https://www.scinai.com/leadership-bios daily 0.75 2023-07-09 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/292585a3-bd7c-4072-a1c2-a4e216f9c8ea/Amir+Reichman.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/ad085348-d38a-4cae-9905-464e44ec0e2c/Tamar+Ben-Yedidia.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/11f64a8d-a4df-4532-b558-f9e67ad3837b/Elad+Mark.jpg https://www.scinai.com/amir-reichman daily 0.75 2024-03-25 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/4136896e-8480-4cec-8725-b2e14a4b203a/amir.PNG https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e3ba3dd9-6422-4a85-a473-f63c14e346b3/107149_gray_circle_linkedin_icon.png https://www.scinai.com/tamarbenyedidia daily 0.75 2025-03-09 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e3ba3dd9-6422-4a85-a473-f63c14e346b3/107149_gray_circle_linkedin_icon.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/c641f7d3-3b55-4239-8786-98deec5db321/Tamar.PNG https://www.scinai.com/elad-mark daily 0.75 2024-03-26 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e3ba3dd9-6422-4a85-a473-f63c14e346b3/107149_gray_circle_linkedin_icon.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/6e0c62d0-93e3-4928-bd35-a7aa80c9c45e/Elad.PNG https://www.scinai.com/uri-ben-or daily 0.75 2024-03-26 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e3ba3dd9-6422-4a85-a473-f63c14e346b3/107149_gray_circle_linkedin_icon.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/27dd0d5f-c12a-4bbd-a4fb-dea83791b82f/Uri_Ben_Or.png https://www.scinai.com/dalit-weinstein-fischer daily 0.75 2024-03-26 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/d45403e0-e074-4040-a076-d97f4aa94e53/Dalit%2BWeinstein%2BFischer.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e3ba3dd9-6422-4a85-a473-f63c14e346b3/107149_gray_circle_linkedin_icon.png https://www.scinai.com/tehila-sonnenfeld daily 0.75 2025-11-19 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/7a93ae0c-e5f9-495e-8a36-2de4c095f20f/DSC07437.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e3ba3dd9-6422-4a85-a473-f63c14e346b3/107149_gray_circle_linkedin_icon.png https://www.scinai.com/oded-ovadia daily 0.75 2024-03-26 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e3ba3dd9-6422-4a85-a473-f63c14e346b3/107149_gray_circle_linkedin_icon.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/6395238f-0396-4f0a-8de8-fe39f04089c2/Oded+Ovadia.JPG https://www.scinai.com/joshua-philipson daily 0.75 2024-03-26 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/4f6b11ac-9b42-4393-a826-b83bbd6a203c/Joshua.PNG https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e3ba3dd9-6422-4a85-a473-f63c14e346b3/107149_gray_circle_linkedin_icon.png https://www.scinai.com/merav-kamensky daily 0.75 2025-11-19 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e3ba3dd9-6422-4a85-a473-f63c14e346b3/107149_gray_circle_linkedin_icon.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b850455c-a9ac-42ee-9bd9-0f2ea32c313c/Meav.PNG https://www.scinai.com/naama-adi-hen daily 0.75 2024-03-26 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e3ba3dd9-6422-4a85-a473-f63c14e346b3/107149_gray_circle_linkedin_icon.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e990922f-38ae-42dc-9a4e-44675966b557/Naama+Adi+Hen.JPG https://www.scinai.com/privacy-policy daily 0.75 2025-09-08 https://www.scinai.com/terms-of-use daily 0.75 2023-10-31 https://www.scinai.com/financial daily 0.75 2023-08-22 https://www.scinai.com/code-of-conduct daily 0.75 2023-09-07 https://www.scinai.com/nominating-and-governance-committee-charter daily 0.75 2023-09-07 https://www.scinai.com/compensation-committee-charter daily 0.75 2023-09-07 https://www.scinai.com/audit-committee-charter daily 0.75 2023-09-07 https://www.scinai.com/mark-germain daily 0.75 2023-09-03 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/ddfbfd59-c226-4bfe-b537-3f9259e38140/Mark+Germain%2C+BiondVax+Chairman+of+the+Board+of+Directors.jpg https://www.scinai.com/jay-green daily 0.75 2023-08-30 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/41a75c69-c44c-44f5-9841-ff89da6d1ffa/Jay+Green%2C+member+of+BiondVax%27s+Board+of+Directors_150x213.jpg https://www.scinai.com/morris-laster daily 0.75 2023-08-30 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/77cd5f37-e9c3-4100-ace0-025b13fa678a/Morris+Laster_150x213.jpg https://www.scinai.com/yael-margolin daily 0.75 2023-08-30 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/6dcc207c-ef55-4ffb-ac2f-c4843ba33ad8/Yael+Marolin.jpg https://www.scinai.com/sam-moed daily 0.75 2023-08-30 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/a9ac8613-339f-4b90-ab90-ec91f8d792c6/Samuel+Moed%2C+Director%2C+BiondVax+Pharmaceuticals+%28jpg%29.jpg https://www.scinai.com/adi-raviv daily 0.75 2023-08-30 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/06d57f9d-dcb7-458a-b629-48ec817bc8fd/Adi+Raviv+-+BiondVax_opt.jpg https://www.scinai.com/avner-rotman daily 0.75 2023-09-03 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/bfb3e501-355a-4a38-a2a8-3ec9caece60d/Avner+Rotman_150x213.jpg https://www.scinai.com/alona-tal daily 0.75 2025-03-06 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/ed480d6e-480c-4b25-b9c0-66183aded806/Alona+Tal.png https://www.scinai.com/contact daily 0.75 2025-10-30 https://www.scinai.com/404 daily 0.75 2023-09-04 https://www.scinai.com/biondvax-is-now-scinai daily 0.75 2023-09-06 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/379a3c37-49bb-41d2-81a9-77444a83c825/SCINAI+LOGO+WHITE.png https://www.scinai.com/boutique-cdmo daily 0.75 2024-03-10 https://www.scinai.com/scinai-cdmo-at-bio-europe-spring-2024 daily 0.75 2024-03-12 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/912b6716-2020-459b-bd95-809b19dfd83f/BIO-Europe+Spring+24_Logo+stacked+KO+Dates%403x.png https://www.scinai.com/solomon-gahtan daily 0.75 2025-11-19 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e21e5c85-41d5-4ee3-8fb7-69053b8466b2/Solomon+Gahtan.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e3ba3dd9-6422-4a85-a473-f63c14e346b3/107149_gray_circle_linkedin_icon.png https://www.scinai.com/home-1 daily 0.75 2025-10-29 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/777f838b-c28a-4f0a-8bd6-829922906f6d/04.jpg Scinai | Biopharmaceutical Innovation & Boutique CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/bc06b316-cbb3-47e8-9042-546ef5b67bc1/02.jpg Scinai | Biopharmaceutical Innovation & Boutique CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/34d2cff7-0baf-4b5c-978e-aa853ca61754/articles_preview_04.jpg Scinai | Biopharmaceutical Innovation & Boutique CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/d8af3818-5f9f-4d71-baca-a6a0f3b6f03b/articles_preview_03.jpg Scinai | Biopharmaceutical Innovation & Boutique CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/3fcde8b9-d917-40a7-885e-56012d857fb5/voyager_suture.jpg Scinai | Biopharmaceutical Innovation & Boutique CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/8f8d103f-0024-440f-909e-c627066a1d99/articles_preview_amir.jpg Scinai | Biopharmaceutical Innovation & Boutique CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/60c6b9c1-55a1-46f3-ba2c-dc0d958fb5c9/articles_preview_science_direct.jpg Scinai | Biopharmaceutical Innovation & Boutique CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/596ad921-1c59-424f-ade6-83f266a00b68/Expert_panel.jpg Scinai | Biopharmaceutical Innovation & Boutique CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/8b19f146-d4ef-4e34-9659-979482a9078f/serpin.jpg Scinai | Biopharmaceutical Innovation & Boutique CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b4a57457-37e6-4da9-b1ca-d37c3ee280a3/hopec.jpg Scinai | Biopharmaceutical Innovation & Boutique CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/90f13d78-f8b5-4010-968e-48e781fa8cb0/US.jpg Scinai | Biopharmaceutical Innovation & Boutique CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/17b23f09-48aa-406f-b542-07022c450868/welcome.jpg Scinai | Biopharmaceutical Innovation & Boutique CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/bc88bc55-5483-430b-bf04-04b2d5c23b59/01_Scinai_banner_mountain_b.jpg Scinai | Biopharmaceutical Innovation & Boutique CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/78c06e67-a0be-4d3b-98e7-a8292c24725b/03_Scinai_banner_Lab.jpg Scinai | Biopharmaceutical Innovation & Boutique CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/4136896e-8480-4cec-8725-b2e14a4b203a/amir.PNG https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/c641f7d3-3b55-4239-8786-98deec5db321/Tamar.PNG https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e428bfd9-4198-4379-86de-f4daad043ef0/Elad.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/59dc125a-9a29-4816-bd90-b8749d579cea/alpaca_lab+copy.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/bf980033-107a-426e-98f2-b09072ea4ec5/01.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/1646f3f3-bbb4-4d36-9d27-99e3235e1e14/04.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/10c36d2e-56c2-4081-a35e-d05e38850e63/02.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/152c4b69-e81a-4489-82bc-3473e207448c/03.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/23fa6ca3-de3b-4271-a9f2-00541a3f1014/Dirk+Goerlich.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/81e28cad-0135-4fa1-aefa-4eca650df375/rsz_1matthias_dobbelstein.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/929c8ad5-5602-4e36-993b-aeae205468eb/image+%284%29.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/7343edc0-3ea1-4a93-b714-bc4670fd86e7/image+%285%29.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/bbb9b290-4646-4bfa-8a6f-8a7d942d6e37/Aseptic+fill+and+finish.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/ccf4dfa5-91b9-4a98-ad5b-a8e5734da207/P1054813.MOV.00_42_21_02.Still001.jpg https://www.scinai.com/cdmo-process-development daily 0.75 2026-01-01 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/de54044a-091d-43d1-8e4a-ed3f8c49e5a5/process_2.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/221a9a8d-3f1b-4270-aaca-dd3da588cfff/down-right-arrow.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/3bd471b6-ee8c-4303-ad7f-c0395e9fcf2c/process_3.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b10a4f58-8f5f-4c6a-8455-de1385315059/down-right-arrow.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/6af39fde-87c2-4084-9da1-2c6339b6c428/process_4.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b10a4f58-8f5f-4c6a-8455-de1385315059/down-right-arrow.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/80ea6d33-5fe7-401e-bbfa-987a345bf957/process_1.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/221a9a8d-3f1b-4270-aaca-dd3da588cfff/down-right-arrow.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/038ff144-bee3-4ec9-8cda-1397d635d144/Zohar+Gadri.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/f725cd17-8a6d-4c19-8b0e-f937554fb52a/IS1_0494.jpg https://www.scinai.com/shareholders daily 0.75 2025-11-16 https://www.scinai.com/cdmo-process-development-1 daily 0.75 2024-07-14 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/038ff144-bee3-4ec9-8cda-1397d635d144/Zohar+Gadri.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/f725cd17-8a6d-4c19-8b0e-f937554fb52a/IS1_0494.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/cd68a37a-4c18-44c6-a44b-80c55dd90fa6/IMG_20220703_100939083_PORTRAIT.jpg https://www.scinai.com/cdmo-analytical-methods-development daily 0.75 2026-01-01 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/02249b5f-3f30-4a60-93c6-a3d02b11c41a/Physicochemical+methods.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b10a4f58-8f5f-4c6a-8455-de1385315059/down-right-arrow.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/44c9d67d-e3ee-4150-8621-319755f33a7b/Spectrophotometry.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/221a9a8d-3f1b-4270-aaca-dd3da588cfff/down-right-arrow.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/27387ebf-e42e-4979-94e6-dc57e99d5290/Merav+Kamensky+-+sq.JPG https://www.scinai.com/cgmp-manufacturing daily 0.75 2026-01-01 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/487a2a69-50ae-4d94-9606-81a09576bdbd/Upstream.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b10a4f58-8f5f-4c6a-8455-de1385315059/down-right-arrow.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/8ceb68e5-c0b5-4e17-bf7d-585fd7156fd3/Media+and+buffer+preparation.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b10a4f58-8f5f-4c6a-8455-de1385315059/down-right-arrow.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/d99ee968-3fc1-47bf-9c0b-b8f00092d375/Downstream.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/221a9a8d-3f1b-4270-aaca-dd3da588cfff/down-right-arrow.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/442d90e6-6058-4120-90a7-2b1ced9648d5/PXL_20230418_071406690.PORTRAIT%7E2.jpg https://www.scinai.com/aseptic-processing daily 0.75 2026-01-01 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/77ba91b2-3e82-4c3a-b9b0-89a15a81e30a/Grade+A+Filling+Machine.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/221a9a8d-3f1b-4270-aaca-dd3da588cfff/down-right-arrow.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/9aae382b-7be5-4b3c-82df-4056bdd46152/Fully+equipped.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b10a4f58-8f5f-4c6a-8455-de1385315059/down-right-arrow.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/442d90e6-6058-4120-90a7-2b1ced9648d5/PXL_20230418_071406690.PORTRAIT%7E2.jpg https://www.scinai.com/quality-and-regulatory-standards daily 0.75 2026-01-01 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/d1f01ac1-013d-46a0-abf8-f94f1ddd5fc0/Quality+Management.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/221a9a8d-3f1b-4270-aaca-dd3da588cfff/down-right-arrow.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/79ec2952-e438-46d3-9792-bb995799683f/CMC+Support.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/221a9a8d-3f1b-4270-aaca-dd3da588cfff/down-right-arrow.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e990922f-38ae-42dc-9a4e-44675966b557/Naama+Adi+Hen.JPG https://www.scinai.com/bioservices daily 0.75 2026-01-01 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/72a2126e-9c4e-43b7-a1df-1b3905379b93/checked.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/c6b454c1-3ebe-4680-b9b2-e14d8e1d030f/Image.png https://www.scinai.com/cdmo-lp-catalog daily 0.75 2024-07-16 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/72a2126e-9c4e-43b7-a1df-1b3905379b93/checked.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/c6b454c1-3ebe-4680-b9b2-e14d8e1d030f/Image.png https://www.scinai.com/investorsrelations daily 0.75 2026-04-02 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/f3e5c4a4-d526-431f-b783-133b4f5d99fb/ppt+copy.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b10a4f58-8f5f-4c6a-8455-de1385315059/down-right-arrow.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b10a4f58-8f5f-4c6a-8455-de1385315059/down-right-arrow.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/975952e6-ccaa-4328-a27c-116d33c57648/event_banner.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/d5f88bcf-fc25-4233-bac2-63bd36997004/site.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/a2200924-8191-4a72-b349-43ca9754a374/presentation+%282%29.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/4147ab14-942e-4bb2-8145-d9e2aab21a21/bar-graph.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b4d3caa0-1a4a-487c-b3e2-74022337e42b/public-relation.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/a18db0a3-fd78-4f69-87ed-9656e8b877d3/SEC+icon_2.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/94360763-e318-4686-be75-6bf056243bbf/online-video.png https://www.scinai.com/cdmo-lp-ebook daily 0.75 2026-01-01 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/38952b6b-06ee-44e1-a176-896d384bef0a/ebook.png https://www.scinai.com/home-2025 daily 1.0 2026-01-01 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/aa6a5963-a21c-463f-999c-d646e4b1e3e2/new+logoaArtboard+1+copy+2.jpg Scinai | Biopharmaceutical Innovation & Boutique CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/056de81b-c321-41bc-9499-efd5a1ff56b8/new+logoaArtboard+1+copy+3.jpg Scinai | Biopharmaceutical Innovation & Boutique CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/8ed6436a-263d-4044-84eb-b7769d49593c/new+logoaArtboard+1+copy+4.jpg Scinai | Biopharmaceutical Innovation & Boutique CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/9d9e9f34-df14-4463-8d86-604ce17d4e2b/new+logoaArtboard+1+copy+5.jpg Scinai | Biopharmaceutical Innovation & Boutique CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/ff23530d-916b-4d22-9ea6-d1ba67a4f6cc/new+logoaArtboard+1+copy.jpg Scinai | Biopharmaceutical Innovation & Boutique CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/eee7189c-f71a-4ef3-af6a-38856678ba48/new+logoaArtboard+1.jpg Scinai | Biopharmaceutical Innovation & Boutique CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/d7e61275-188c-431a-9f71-74462525d52a/technology.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/aafd6a6f-1573-4371-9574-0ca6947e8213/target.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/cad5a29c-de0b-482f-b4f7-5a37246cfc8a/pie-chart+%281%29.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/9470955c-37c6-44d0-8df5-f52fbfcb1008/money-bag.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/8e2bec23-d2a9-4332-88f2-04392bd0ca7c/Professor+Dr.+Dirk+Go%CC%88rlich.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/70b9de7f-4855-464b-91d1-4b76b9572511/Dobbelstein_Matthias_2.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/de9e7529-b5d3-4132-a0ec-71f012f1a45f/nan_ab.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/691bc2ea-0c25-4622-8a72-653fc2bf8696/flow+chart+new-10.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b9af1f5b-0676-4380-ae14-39b41c7be15a/flow+chart+new-12.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/0fc8da80-4c99-4b12-b2f4-cd1f853a4f6e/flow_chart+mobile+full.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/a5284a4d-7aec-4a6a-a216-9c0e7d230761/flow+chart+new-01.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/faa3cbb7-286b-4acd-a5be-f1331a2275b9/flow+chart+new-06.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/ac9d9e3a-8947-423c-b9cb-0f835f4325ad/flow+chart+new-07.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/d3a7ff67-8284-4eb5-9011-6f62d24630d6/flow+chart+new-08.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/3898159c-39f3-4cdb-9976-15f2771e69db/flow+chart+new-09.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/60959115-9ba3-45ff-a8f2-682abb411d29/flow+chart+new-12.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/82b28801-3a1b-4e53-b979-a4672ab0d869/flow+chart+new-11.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/582b8a23-cc40-493f-bad9-60d7fe061486/08.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/7b30384e-0ea2-4be9-b435-7c21b09b197a/flow+chart+new-09.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b9af1f5b-0676-4380-ae14-39b41c7be15a/flow+chart+new-12.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/691bc2ea-0c25-4622-8a72-653fc2bf8696/flow+chart+new-10.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b9af1f5b-0676-4380-ae14-39b41c7be15a/flow+chart+new-12.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/67333e2a-08cd-4907-886c-cc116d5ee694/IMAGESsquare+01.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/197e9520-8911-4034-80f5-c1148e9e6e5e/IMAGESsquare+03.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b2015218-22ae-4c15-a91c-48451d76c0ed/IMAGES04.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/618167d1-875e-47fc-96a2-9a00b09b8984/Scinai_Ebook-01.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/9c4694bb-390b-48f0-8bd9-072e856ba613/CLEAN+ROOM.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/7a2359f8-8a6d-4b2c-8cab-458803a54a63/image001.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/7ad1bdd5-04a9-4d5a-a9e0-37f9c5a8c1f4/team_2.png https://www.scinai.com/cdmo daily 0.75 2026-01-01 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/aa6a5963-a21c-463f-999c-d646e4b1e3e2/new+logoaArtboard+1+copy+2.jpg Bioservices Biologics CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/056de81b-c321-41bc-9499-efd5a1ff56b8/new+logoaArtboard+1+copy+3.jpg Bioservices Biologics CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/8ed6436a-263d-4044-84eb-b7769d49593c/new+logoaArtboard+1+copy+4.jpg Bioservices Biologics CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/9d9e9f34-df14-4463-8d86-604ce17d4e2b/new+logoaArtboard+1+copy+5.jpg Bioservices Biologics CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/ff23530d-916b-4d22-9ea6-d1ba67a4f6cc/new+logoaArtboard+1+copy.jpg Bioservices Biologics CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/eee7189c-f71a-4ef3-af6a-38856678ba48/new+logoaArtboard+1.jpg Bioservices Biologics CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e796622e-a1bc-4d62-9cbb-b35e2e620bac/IMAGESLABRATORY.jpg Bioservices Biologics CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/53687f33-fd95-4c67-af2c-aeb72e9f4d1c/GALLERY+CDMOsquare+03+copy+4.jpg Bioservices Biologics CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/75456300-ea15-4df5-92ce-7368766b727e/IMAGESAnalytical+methods+.jpg Bioservices Biologics CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/f17e5b23-0562-42bb-917d-ac8d2438ed41/IMAGESAnalytical+methods++copy.jpg Bioservices Biologics CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/d50139c7-b398-40a7-8882-ac01f125d040/GALLERY+CDMOsquare+01.jpg Bioservices Biologics CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/8f476241-4549-4385-bef5-cb16e2ba696c/GALLERY+CDMOsquare+03+copy+2.jpg Bioservices Biologics CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/f714fecb-2b73-4e54-a830-5229a64b2253/GALLERY+CDMOsquare+03+copy.jpg Bioservices Biologics CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/18300aca-3a13-4d45-94fd-07148f646245/lab.jpg Bioservices Biologics CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/792398b2-e94f-484e-94d9-51b7e4b3a12f/GALLERY+CDMOsquare+03.jpg Bioservices Biologics CDMO https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/0fc8da80-4c99-4b12-b2f4-cd1f853a4f6e/flow_chart+mobile+full.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/a5284a4d-7aec-4a6a-a216-9c0e7d230761/flow+chart+new-01.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/faa3cbb7-286b-4acd-a5be-f1331a2275b9/flow+chart+new-06.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/ac9d9e3a-8947-423c-b9cb-0f835f4325ad/flow+chart+new-07.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/d3a7ff67-8284-4eb5-9011-6f62d24630d6/flow+chart+new-08.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/3898159c-39f3-4cdb-9976-15f2771e69db/flow+chart+new-09.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/60959115-9ba3-45ff-a8f2-682abb411d29/flow+chart+new-12.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/82b28801-3a1b-4e53-b979-a4672ab0d869/flow+chart+new-11.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/582b8a23-cc40-493f-bad9-60d7fe061486/08.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/7b30384e-0ea2-4be9-b435-7c21b09b197a/flow+chart+new-09.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b9af1f5b-0676-4380-ae14-39b41c7be15a/flow+chart+new-12.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/691bc2ea-0c25-4622-8a72-653fc2bf8696/flow+chart+new-10.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b9af1f5b-0676-4380-ae14-39b41c7be15a/flow+chart+new-12.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/23457c0f-f28b-4a1d-843c-814d6a297f0a/IMAGEScGMP.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b30b4919-b937-4fc9-902d-a2eb3708046e/IMAGESAKTA.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/a584b5af-65b5-478a-8136-eaa21fb13ff5/IMAGESsquare+01.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/59ae445c-2420-45fb-85fd-fb3264519c11/IMAGESAnalytical+methods++copy.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/f23d87c9-0a0a-4d08-971c-bc8f439b21cc/IMAGESAnalytical+methods%250A.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/de8df94b-1d9b-4b5a-af56-05a9da0d10b8/estee.jpeg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/1cfd25ce-c2df-4c88-ac70-f517c664edd1/loan.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/d6025693-e8ab-4ec3-ba60-634d97767e46/play-button.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/76face8a-d98e-4f1b-8580-18a2e1b5ffa6/co-01+copy.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/a8bdffe7-6466-4685-a88b-f3b2d7efee67/serpin+logo.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/7df8e9b3-7d90-4103-8c4f-a4e1ed5a264d/trigone_logo+copy.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/d28c9372-689e-494e-9b07-5c05bd405b37/ayana-pharma-1646306490.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/ba112abe-69fe-4a14-bcff-8e7b46b61649/344Asset-4%402x-1-1+copy.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/9450bfef-6254-4400-a5eb-93d939725918/logo-1+copy.png https://www.scinai.com/meital-portugal daily 0.75 2025-11-19 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e3ba3dd9-6422-4a85-a473-f63c14e346b3/107149_gray_circle_linkedin_icon.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b6d9d783-0d5d-4078-9864-b40d81b22241/DSC07553.jpg https://www.scinai.com/tintradermal-il-17 daily 0.75 2026-03-09 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/abfe7034-e3b2-483e-abd8-6b2dab32a987/patient.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/ee328d5d-0778-4b26-8341-33d943caecb7/dermatology.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/f288a0c5-9ae5-4e70-b939-99f4bc222f52/iStock-1186513808.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/a5639437-dddd-4b0d-90dc-904fbe6a8a01/mesogun-skin+02+copy.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/a6d3b186-ae79-45c5-bd48-c1574c6a3738/target+%281%29.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/d1e62269-33af-482d-a352-1fd61fb8122a/skincare+%281%29.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/58236687-f0ea-41b9-abef-c7252c7852b4/delivered.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/6bd14841-a8e9-437a-bc06-6801847a0711/accurate.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/05f13366-6742-4018-b3e0-b3099fd0a23f/money-bag+%281%29.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/59512c51-8938-442b-9ade-8433ace37661/healthcare.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/0e830317-5cc0-4a90-bf57-74fd7162a246/Ex-Vivo.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/65bdd1c6-7ae8-491b-8c97-5dc2dce7837e/1.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/10f9861e-cbad-4ee0-8f21-d3a196eeb7f8/2.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/9005d638-9f70-456a-8071-9d91fa5bc643/negative+control.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b27efa43-76f2-4392-8f26-2b0f32bed01e/Secukinumab.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/43489e09-9e19-4248-85b2-2ca25a85ac50/Nanoab+once+a+week.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/abe268d3-b285-455e-b02a-cf26c7a6df4b/Future+Plans+%26+Timeline+.png https://www.scinai.com/pipeline daily 0.75 2026-03-09 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/ef7b95b9-9549-49eb-9dd5-64851a306576/alpaca+copy.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/25f7932d-4f9e-4df4-b0e9-f0d88c07e2c4/antigen+copy.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/2e6fd752-f63b-408f-b37b-eec6aff3a076/Screenshot+2026-03-02+at+13.48.33.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/62a33747-cecd-4c85-8ee3-3e4f7465f3b5/update+pipeline+bars-01.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/90f78adb-5813-43cc-82b7-00a7a52e6a02/update+pipeline+bars-02.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/1ee59436-7129-4813-bbf7-56bc28294cc2/update+pipeline+bars-03.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/1ee59436-7129-4813-bbf7-56bc28294cc2/update+pipeline+bars-03.png https://www.scinai.com/pemphigus-vulgaris-pc111 daily 0.75 2026-03-09 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/aa3a6d78-a0dd-4311-aea0-1986d063a480/frontiersin.jpg Pemphigus Vulgaris PC111 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e621df4f-a29a-409f-b770-12c77a445299/journal+dermatological.jpg Pemphigus Vulgaris PC111 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/74c29678-60b5-4534-9d55-e38cf5ecfb35/SIDeMaST.jpg Pemphigus Vulgaris PC111 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/abfe7034-e3b2-483e-abd8-6b2dab32a987/patient.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/45e6d955-d8a9-40d2-89f3-5f6feb1bf3a4/dead-body+%281%29.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/abfe7034-e3b2-483e-abd8-6b2dab32a987/patient.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/45e6d955-d8a9-40d2-89f3-5f6feb1bf3a4/dead-body+%281%29.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/26c3727e-dc7d-4940-8dcc-0f7af75790f5/generative-ai-png-winner-trophy-pink-golden-champion-cup.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/d1b9bde4-8937-4877-a791-fb78013f4600/iStock-2160822570.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/a1eafa0f-da93-4922-bf11-56bbac52063d/iStock-1826415349.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/c498353b-eab9-4017-b24b-3ffc1ac547fc/clock.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/7e74d9f3-25dd-4b66-b11a-f50a747425c1/health-check.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/982b9d0a-b8f9-4946-bdae-dba45d4daff5/shield.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/953efaa9-0f2c-4f5d-8a36-46cc987dafb1/good-quality.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/2b0d8b85-c446-4e84-968e-5629028c6fbb/Ex-Vivo-01.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b665113e-5348-4dfe-ba66-8db40f964fdf/Lotti-et-al.2025_JDT_Treatment-of-pemphigus-and-other-neglected-skin-conditions-with-PC111-a-human-anti-Fas-Ligand-monoclonal-antibody-a-potential-disease-modifier.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/9adac4e9-0eb3-4266-8e88-18c69774a437/%25+blisters.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/6a796028-dda2-46ae-bc52-eb387b9626fa/Ex+vivo+%28Pemphigus+models%29-01+copy.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/90bf7111-02a2-4443-b9ed-004343998641/Picture1.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/abe268d3-b285-455e-b02a-cf26c7a6df4b/Future+Plans+%26+Timeline+.png https://www.scinai.com/systemic-bi-specific-il17 daily 0.75 2026-03-09 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/abfe7034-e3b2-483e-abd8-6b2dab32a987/patient.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/ee328d5d-0778-4b26-8341-33d943caecb7/dermatology.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/ee328d5d-0778-4b26-8341-33d943caecb7/dermatology.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/abfe7034-e3b2-483e-abd8-6b2dab32a987/patient.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/d4f0cb4b-d2cd-4e7b-b7bc-d650b484e6be/AdobeStock_1862072423.jpeg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/4c09d250-c7ba-4207-927c-4a5df6bd2632/banner+03+copy.jpg https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/a6d3b186-ae79-45c5-bd48-c1574c6a3738/target+%281%29.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/d1e62269-33af-482d-a352-1fd61fb8122a/skincare+%281%29.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/6eacaead-d6dd-4c0e-b4b9-4ef210d0d76c/prevention.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/9f4970ef-bdde-40c9-baad-c85e29f721b0/health-insurance+%281%29.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/4a8443ac-9147-4174-80cb-1dbe67988fbe/bacteria.png https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/518ef45c-2e04-4d92-a693-826783afe5be/money-bag.png https://www.scinai.com/team2 daily 0.75 2023-07-02 https://www.scinai.com/team2/tamar-ben-yedidia2 monthly 0.5 2023-07-02 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/ad085348-d38a-4cae-9905-464e44ec0e2c/Tamar+Ben-Yedidia.jpg https://www.scinai.com/team2/amir-reichman monthly 0.5 2023-07-02 https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/292585a3-bd7c-4072-a1c2-a4e216f9c8ea/Amir+Reichman.jpg